Showing results (231-240 of 240) with videos related to
Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
The Science of the Total Environment|February 11, 2026
Wastewater-based surveillance of hepatitis A virus across municipalities and neighbourhoods in Alberta, CanadaR Benson Weyant, Aito Ueno, Barbara Waddell, et al.Viruses|December 23, 2022
Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)Carla S Coffin, Sarah Haylock-Jacobs, Karen Doucette, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced MelanomaRobert H I Andtbacka, Howard L Kaufman, Frances Collichio, et al.CMAJ Open|October 24, 2019
Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV NetworkCarla S Coffin, Alnoor Ramji, Curtis L Cooper, et al.Journal for Immunotherapy of Cancer|March 3, 2026
Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signalingVictoria Roulstone, Joan Kyula, Elizabeth Appleton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE)Michael K Wong, Mohammed M Milhem, Joseph J Sacco, et al.The Lancet. Gastroenterology & Hepatology|March 30, 2023
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysisAdelina Artenie, Jack Stone, Hannah Fraser, et al.Journal of Hepatology|August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis BMaria Buti, Jeong Heo, Yasuhito Tanaka, et al.The New England Journal of Medicine|May 28, 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus InfectionJinlin Hou, Seng-Gee Lim, Maria Buti, et al.Journal of Hepatology|April 8, 2023
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countriesHomie A Razavi, Maria Buti, Norah A Terrault, et al.Pageof 24